Perspective Therapeutics Stock Price History
| CATX Stock | 3.47 0.47 15.67% |
Below is the normalized historical share price chart for Perspective Therapeutics extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Perspective Therapeutics stands at 3.47, as last reported on the 25th of November, with the highest price reaching 3.59 and the lowest price hitting 2.94 during the day.
If you're considering investing in Perspective Stock, it is important to understand the factors that can impact its price. Perspective Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.24, which implies the firm had a -0.24% return per unit of risk over the last 3 months. Perspective Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Perspective Therapeutics' Variance of 61.4, risk adjusted performance of (0.17), and Coefficient Of Variation of (439.19) to confirm the risk estimate we provide.
At this time, Perspective Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 34.8 M in 2024, whereas Common Stock is likely to drop slightly above 103.4 K in 2024. . At this time, Perspective Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to rise to 57.93 in 2024, whereas Price Earnings Ratio is likely to drop (28.89) in 2024. Perspective Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of November 2005 | 200 Day MA 12.7391 | 50 Day MA 11.5164 | Beta 1.467 |
Perspective |
Sharpe Ratio = -0.2362
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CATX |
Estimated Market Risk
| 7.92 actual daily | 70 70% of assets are less volatile |
Expected Return
| -1.87 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Perspective Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Perspective Therapeutics by adding Perspective Therapeutics to a well-diversified portfolio.
Price Book 0.714 | Enterprise Value Ebitda (21.91) | Price Sales 150.6285 | Shares Float 43.5 M | Wall Street Target Price 18.1667 |
Perspective Therapeutics Stock Price History Chart
There are several ways to analyze Perspective Stock price data. The simplest method is using a basic Perspective candlestick price chart, which shows Perspective Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 12, 2024 | 15.84 |
| Lowest Price | November 21, 2024 | 3.0 |
Perspective Therapeutics November 25, 2024 Stock Price Synopsis
Various analyses of Perspective Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Perspective Stock. It can be used to describe the percentage change in the price of Perspective Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Perspective Stock.| Perspective Therapeutics Price Rate Of Daily Change | 1.16 | |
| Perspective Therapeutics Price Action Indicator | 0.44 | |
| Perspective Therapeutics Price Daily Balance Of Power | 0.72 |
Perspective Therapeutics November 25, 2024 Stock Price Analysis
Perspective Stock Price History Data
The price series of Perspective Therapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 12.84 with a coefficient of variation of 21.65. The prices are distributed with arithmetic mean of 12.46. The median price for the last 90 days is 12.65. The company had 1:10 stock split on 17th of June 2024.| Open | High | Low | Close | Volume | ||
11/25/2024 | 3.06 | 3.59 | 2.94 | 3.47 | ||
| 11/22/2024 | 3.06 | 3.59 | 2.94 | 3.47 | 9,647,749 | |
| 11/21/2024 | 4.47 | 4.59 | 2.94 | 3.00 | 12,607,696 | |
| 11/20/2024 | 6.79 | 6.87 | 6.01 | 6.17 | 1,156,611 | |
| 11/19/2024 | 6.55 | 7.08 | 6.55 | 6.78 | 1,561,929 | |
| 11/18/2024 | 7.95 | 7.95 | 6.79 | 6.96 | 1,501,901 | |
| 11/15/2024 | 8.93 | 8.93 | 7.87 | 7.88 | 1,849,333 | |
| 11/14/2024 | 10.03 | 10.06 | 8.86 | 8.92 | 1,473,384 | |
| 11/13/2024 | 10.77 | 10.77 | 9.85 | 9.93 | 1,156,992 | |
| 11/12/2024 | 11.13 | 11.17 | 10.51 | 10.67 | 1,065,408 | |
| 11/11/2024 | 11.50 | 11.69 | 11.03 | 11.09 | 538,510 | |
| 11/08/2024 | 11.71 | 11.83 | 11.13 | 11.25 | 607,286 | |
| 11/07/2024 | 12.26 | 12.42 | 11.67 | 11.78 | 1,049,684 | |
| 11/06/2024 | 12.51 | 12.82 | 12.18 | 12.34 | 775,631 | |
| 11/05/2024 | 12.15 | 12.39 | 11.95 | 12.34 | 426,052 | |
| 11/04/2024 | 12.09 | 12.90 | 11.79 | 12.19 | 553,811 | |
| 11/01/2024 | 11.97 | 12.21 | 11.64 | 12.09 | 482,202 | |
| 10/31/2024 | 11.40 | 11.95 | 11.40 | 11.81 | 620,938 | |
| 10/30/2024 | 11.81 | 11.94 | 11.43 | 11.47 | 285,176 | |
| 10/29/2024 | 11.76 | 12.09 | 11.69 | 11.87 | 575,110 | |
| 10/28/2024 | 11.77 | 12.46 | 11.55 | 11.91 | 746,732 | |
| 10/25/2024 | 11.93 | 11.96 | 11.50 | 11.53 | 515,250 | |
| 10/24/2024 | 12.28 | 12.31 | 11.80 | 11.89 | 307,088 | |
| 10/23/2024 | 12.29 | 12.40 | 11.65 | 11.69 | 574,554 | |
| 10/22/2024 | 12.69 | 12.69 | 12.19 | 12.39 | 297,629 | |
| 10/21/2024 | 12.57 | 12.84 | 12.40 | 12.70 | 847,732 | |
| 10/18/2024 | 12.30 | 12.72 | 11.93 | 12.65 | 406,822 | |
| 10/17/2024 | 13.13 | 13.19 | 12.09 | 12.15 | 1,260,897 | |
| 10/16/2024 | 12.57 | 13.15 | 12.44 | 13.00 | 745,220 | |
| 10/15/2024 | 12.26 | 13.04 | 12.10 | 12.56 | 1,323,022 | |
| 10/14/2024 | 12.47 | 12.89 | 12.02 | 12.29 | 935,885 | |
| 10/11/2024 | 11.50 | 12.79 | 9.66 | 12.66 | 5,182,976 | |
| 10/10/2024 | 12.90 | 13.35 | 12.63 | 13.25 | 354,069 | |
| 10/09/2024 | 13.10 | 13.16 | 12.60 | 13.10 | 706,941 | |
| 10/08/2024 | 13.11 | 13.44 | 12.98 | 13.17 | 402,019 | |
| 10/07/2024 | 13.20 | 13.34 | 12.91 | 13.13 | 390,595 | |
| 10/04/2024 | 13.42 | 13.56 | 13.20 | 13.35 | 345,798 | |
| 10/03/2024 | 13.12 | 13.40 | 12.87 | 13.21 | 975,663 | |
| 10/02/2024 | 12.83 | 13.39 | 12.55 | 13.21 | 1,289,916 | |
| 10/01/2024 | 13.41 | 13.44 | 12.40 | 12.63 | 1,049,986 | |
| 09/30/2024 | 12.70 | 13.43 | 12.50 | 13.35 | 1,118,168 | |
| 09/27/2024 | 12.45 | 12.89 | 12.33 | 12.57 | 484,139 | |
| 09/26/2024 | 12.41 | 12.73 | 11.97 | 12.26 | 1,006,581 | |
| 09/25/2024 | 12.80 | 12.95 | 12.10 | 12.16 | 875,393 | |
| 09/24/2024 | 12.41 | 12.48 | 11.88 | 12.28 | 564,471 | |
| 09/23/2024 | 13.45 | 13.45 | 11.90 | 12.23 | 1,049,537 | |
| 09/20/2024 | 13.42 | 13.90 | 13.16 | 13.23 | 4,198,462 | |
| 09/19/2024 | 13.96 | 14.19 | 13.34 | 13.47 | 780,352 | |
| 09/18/2024 | 13.37 | 13.99 | 13.28 | 13.35 | 664,745 | |
| 09/17/2024 | 13.19 | 13.43 | 12.89 | 13.32 | 687,137 | |
| 09/16/2024 | 15.20 | 15.28 | 12.95 | 13.12 | 2,723,928 | |
| 09/13/2024 | 16.02 | 16.02 | 14.90 | 15.10 | 830,249 | |
| 09/12/2024 | 15.73 | 16.19 | 15.48 | 15.84 | 646,669 | |
| 09/11/2024 | 15.63 | 15.86 | 15.21 | 15.65 | 1,482,390 | |
| 09/10/2024 | 15.67 | 16.31 | 15.50 | 15.82 | 599,952 | |
| 09/09/2024 | 15.35 | 15.98 | 15.26 | 15.61 | 580,469 | |
| 09/06/2024 | 15.57 | 15.65 | 14.51 | 15.26 | 414,415 | |
| 09/05/2024 | 15.00 | 15.77 | 14.86 | 15.44 | 1,573,741 | |
| 09/04/2024 | 14.12 | 15.03 | 14.04 | 14.98 | 454,281 | |
| 09/03/2024 | 15.55 | 15.94 | 13.95 | 14.18 | 775,480 | |
| 08/30/2024 | 15.54 | 16.13 | 15.54 | 15.80 | 949,353 |
About Perspective Therapeutics Stock history
Perspective Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Perspective is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Perspective Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Perspective Therapeutics stock prices may prove useful in developing a viable investing in Perspective Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.2 M | 34.8 M | |
| Net Loss | -6.5 M | -6.9 M |
Perspective Therapeutics Quarterly Net Working Capital |
|
Perspective Therapeutics Stock Technical Analysis
Perspective Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Perspective Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Perspective Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Perspective Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Perspective to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.83) | |||
| Total Risk Alpha | (3.03) | |||
| Treynor Ratio | (6.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.